scispace - formally typeset
M

Michael R. Jacobs

Researcher at University Hospitals of Cleveland

Publications -  473
Citations -  25197

Michael R. Jacobs is an academic researcher from University Hospitals of Cleveland. The author has contributed to research in topics: Streptococcus pneumoniae & Penicillin. The author has an hindex of 76, co-authored 452 publications receiving 23163 citations. Previous affiliations of Michael R. Jacobs include Rockefeller University & American Red Cross.

Papers
More filters
Journal ArticleDOI

Adult chronic rhinosinusitis: Definitions, diagnosis, epidemiology, and pathophysiology

TL;DR: A Task Force was convened by the Sinus and Allergy Health Partnership to summarize much of the current and important information available regarding the prevalence, economic impact, pathophysiology, common inflammatory mediators, and the role of infectious microbes such as bacteria and fungi in CRS to establish a standard and usable definition.
Journal ArticleDOI

Emergence of multiply resistant pneumococci.

TL;DR: Carriers of Types 6A and 19A penicillin-resistant pneumococci, resistant to antibiotic concentrations ranging between 0.12 and 4 microgram per milliliter were found in 29 of 543 pediatric patients and 2 of 434 hospital staff members in Johannesburg in July, 1977.
Journal ArticleDOI

Clinical features and management of human monkeypox: a retrospective observational study in the UK

Hugh Adler, +138 more
TL;DR: The longitudinal clinical course of monkeypox in a high-income setting, coupled with viral dynamics, and any adverse events related to novel antiviral therapies are described, to highlight the urgent need for prospective studies of antivirals for this disease.
Journal ArticleDOI

Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.

TL;DR: Recommendations to improve surveillance include establishing criteria for setting susceptibility breakpoints for clinically appropriate antimicrobials to ensure relevance for treating AOM, testing middle ear fluid or nasal swab isolates in addition to sterile site isolates and testing of drugs that are useful in treating Aom.